BioCentury
ARTICLE | Financial News

Aastrom proposes follow-on

May 6, 2013 7:00 AM UTC

Aastrom Biosciences Inc. (NASDAQ:ASTM), Ann Arbor, Mich. Business: Gene/Cell therapy Date announced: 4/29/13 Type: Follow-on To be raised: Up to $25 million Shares: TBD Price prior: $0.69 Underwriter:...